PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
64.98
-0.97 (-1.47%)
Sep 29, 2026, 4:00 PM EDT - Market closed
PTC Therapeutics Market Cap
PTC Therapeutics has a market cap or net worth of $5.42 billion as of September 29, 2026. Its market cap has increased by 15.77% in one year.
Market Cap
5.42B
Enterprise Value
6.21B
1-Year Change
15.77%
Ranking
Category
Stock Price
$64.98
ChartMarket Cap Chart
Since June 20, 2013, PTC Therapeutics's market cap has increased from $366.20M to $5.42B, an increase of 1,381.42%. That is a compound annual growth rate of 22.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 5.42B | -11.05% |
| Dec 31, 2025 | 6.10B | 75.18% |
| Dec 31, 2024 | 3.48B | 67.39% |
| Dec 29, 2023 | 2.08B | -24.20% |
| Dec 30, 2022 | 2.74B | -2.56% |
| Dec 31, 2021 | 2.82B | -32.38% |
| Dec 31, 2020 | 4.16B | 40.68% |
| Dec 31, 2019 | 2.96B | 70.95% |
| Dec 31, 2018 | 1.73B | 150.23% |
| Dec 29, 2017 | 692.00M | 84.83% |
| Dec 30, 2016 | 374.40M | -66.28% |
| Dec 31, 2015 | 1.11B | -36.17% |
| Dec 31, 2014 | 1.74B | 311.45% |
| Dec 31, 2013 | 422.80M | 15.46% |
| Jun 20, 2013 | 366.20M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 5.98B |
| Travere Therapeutics | 5.80B |
| Mirum Pharmaceuticals | 5.71B |
| Kodiak Sciences | 5.64B |
| Oruka Therapeutics | 5.57B |
| Cogent Biosciences | 5.53B |
| CRISPR Therapeutics AG | 5.23B |
| Definium Therapeutics | 5.16B |